LC-MS-based serum metabolomics analysis and potential biomarkers for oxaliplatin induced neurotoxicity in colorectal cancer.

MLA

Hua, Yujiao, et al. “LC-MS-Based Serum Metabolomics Analysis and Potential Biomarkers for Oxaliplatin Induced Neurotoxicity in Colorectal Cancer.” Journal of Pharmaceutical and Biomedical Analysis, vol. 252, Jan. 2025, p. 116492. EBSCOhost, https://doi.org/10.1016/j.jpba.2024.116492.

APA

Hua, Y., Lv, J., Zhang, Y., Ding, Y., & Chen, J. (2025). LC-MS-based serum metabolomics analysis and potential biomarkers for oxaliplatin induced neurotoxicity in colorectal cancer. Journal of Pharmaceutical and Biomedical Analysis, 252, 116492. https://doi.org/10.1016/j.jpba.2024.116492

Chicago

Hua, Yujiao, Juan Lv, Yan Zhang, Yongjuan Ding, and Jinghua Chen. 2025. “LC-MS-Based Serum Metabolomics Analysis and Potential Biomarkers for Oxaliplatin Induced Neurotoxicity in Colorectal Cancer.” Journal of Pharmaceutical and Biomedical Analysis 252 (January): 116492. doi:10.1016/j.jpba.2024.116492.